-NOVEMBER 2012 - Dr. Steven Fluharty Delivers Capital Hill Briefing on the Impacts of Sequestration
Steven J. Fluharty, Ph.D. is a Professor of Pharmacology, Psychology and Neuroscience and the Senior Vice Provost for Research at the University of Pennsylvania. In this capacity Dr. Fluharty shapes policy and advances administrative initiatives for the University’s billion dollar research enterprise as well as plays a leadership role in strategic planning for research and administers the development of new research facilities. He also helps to oversee campus-wide research planning efforts, linkages between the University and industry, and the transfer of technologies from University laboratories to the public sector. In addition, he governs the research activities of Provostial Centers and Institutes, particularly those involving interdisciplinary collaboration.
- NOVEMBER 13, 2012 - NIH Awards Penn Scientists $10 million Over Five Years for Innovative Research on Single Cells
James Eberwine, PhD, Elmer Holmes Bobst Professor of Pharmacology in the Perelman School of Medicine, andJunhyongKim, PhD, Edmund J. and Louise W. Kahn Professor of Biology in the School of Arts and Sciences, will be studying the role of how messenger RNA (mRNA) molecules vary in their function in individual cells with a five-year, $10 million grant from the National Institutes of Health (NIH). Their award is supported by the NIH Common Fund and is part of three initiatives of the Single Cell Analysis Program (SCAP). Eberwine and Kim are also Co-directors of thePenn Genomic Frontiers Institute.
- NOVEMBER 4, 2012 - Penn Medicine's Daniel J. Rader, MD, Receives American Heart Association's Clinical Research Prize
Daniel J. Rader, MD, professor of Medicine and chief, Division of Translational Medicine and Human Genetics, at the Perelman School of Medicine at the University of Pennsylvania, has been awarded the American Heart Association’s (AHA) Clinical Research Prize for developing new methods to identify factors regulating the metabolism of fat particles in the bloodstream and testing their impact on the development of atherosclerosis. Dr. Rader received the award on November 4th during the opening ceremony of the AHA Scientific Sessions in Los Angeles, CA.
